Miltenyi Biotec, a global leader in cell and gene therapy solutions, has inaugurated a cutting-edge Cell & Gene Therapy Center in Genome Valley, Hyderabad. This strategic expansion reinforces the company’s commitment to accelerating innovation in advanced therapies, particularly in combating diseases such as cancer and genetic disorders.

The new facility serves as a hub for pioneering research, development, and manufacturing of next-generation cell and gene therapies. It aligns with India’s growing biopharmaceutical ecosystem, offering state-of-the-art infrastructure and technical expertise to support clinical and commercial-scale production.

Bridging Innovation and Accessibility

Genome Valley, a leading life sciences cluster in Asia, provides a dynamic environment for innovation, and Miltenyi Biotec’s presence strengthens the region’s role in shaping the future of precision medicine. The center is expected to facilitate collaborations with research institutions, biotech startups, and pharmaceutical companies, driving advancements in personalized therapies.

 “MITC is a pivotal step in accelerating the global revolution in cell and gene therapies. We are dedicated to empowering the scientific community and transforming the lives of patients worldwide. This centre reflects our ongoing commitment to advancing medical research and offering robust solutions in cell and gene therapy.’‘ Toon Overstijns, Managing Director, Miltenyi Biomedicine, Member of the Board, Miltenyi Biotec said in a release.

Advancing the Cell & Gene Therapy Ecosystem

Miltenyi Biotec’s investment in Genome Valley underscores the growing importance of India as a global hub for cell and gene therapy research. The facility is poised to support end-to-end solutions, from early-stage R&D to clinical-scale manufacturing, fostering a robust pipeline of novel therapeutics.

This move also reflects the increasing demand for advanced biomanufacturing capabilities and regulatory support in the region, catering to both domestic and international markets.

A Step Forward in Global Healthcare Innovation

As cell and gene therapies gain momentum worldwide, Miltenyi Biotec’s expansion in India signals a significant step toward making these transformative treatments more widely available. The company continues to advance its mission of shaping the future of medicine through cutting-edge biotechnology solutions.